Ardelyx, Inc. has maintained a Hold rating due to slowing revenue growth and ongoing reimbursement challenges, despite nearly $500 million in annual revenue. The company's 2026 revenue guidance for its IBSRELA drug was lowered to $350–$370 million, and its XPHOZAH product faces significant Medicare reimbursement hurdles, which dampen growth prospects. While Ardelyx aims for profitability by 2027, concerns remain about its heavy reliance on the drug tenapanor and a lack of pipeline diversification. The CIC opportunity could potentially boost growth, but execution risks and payer access issues remain key challenges in the near term.
Ardelyx's recent performance is provided here as market context. For readers following health-sector stocks, 48 of 150 priced US health stocks rose while 101 fell today. Notable movers include MRVI at USD 7.80 with a -7.74% change, HIMS at USD 27.64 with a -6.84% change and 85% sell order activity, and CTXR at USD 0.53 with a -6.73% change and 93% sell order activity. These figures are as of Oct 31, 2026 04:31 WIB.
Mohawk Industries announced a new $500 million stock buyback program alongside strategic guidelines focusing on strengthening market position, driving innovation, improving profitability, and disciplined capital allocation. The company plans to inves...
3E Network Technology Group Limited received a notice from Nasdaq that its Class A shares will be delisted due to the share price falling below $1.00 for 30 consecutive business days. The company is not eligible for a compliance period because of a r...
Philips has introduced the HyperVue Integrated System in the U.S., a fixed, single-room setup combining DeepOCT+NIRS imaging with X1-FFR physiology assessment for coronary interventions. This system is designed to streamline cath lab workflows by kee...
Atlas Copco Group completed Expansion Week in the US, unveiling three major manufacturing expansions in New York and South Carolina. The new facilities will increase production of oil-free compressors, dry vacuum pumps, and gas and process equipment,...
Former President Donald Trump has endorsed Republican Anna Paulina Luna for reelection in Florida's 13th Congressional District, praising her as a "MAGA Warrior" and highlighting her economic and energy policies. Luna faces Democratic challenger Leel...
